Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara L Weber

Showing results (11-20 of 82) with videos related to

Pageof 9
Sort By:
Cancer Letters|June 22, 2005
Measurement and relevance of neuroblastoma DNA copy number changes in the post-genome eraYael P Mosse, Joel Greshock, Barbara L Weber, et al.
Journal of Consulting and Clinical Psychology|February 28, 2002
Why not to screen high-risk women anticipating BRCA1/BRCA2 testing for psychological distressNili R Benazon, James C Coyne, Kathleen A Calzone, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 15, 2003
Application of breast cancer risk prediction models in clinical practiceSusan M Domchek, Andrea Eisen, Kathleen Calzone, et al.
The Lancet. Oncology|December 10, 2003
Identification and high-resolution mapping of a constitutional 11q deletion in an infant with multifocal neuroblastomaYael Mosse, Joel Greshock, Allison King, et al.
Cancer Research|June 3, 2004
Structure-based assessment of missense mutations in human BRCA1: implications for breast and ovarian cancer predispositionNebojsa Mirkovic, Marc A Marti-Renom, Barbara L Weber, et al.
Cancer Research|April 19, 2007
Cancer cell lines as genetic models of their parent histology: analyses based on array comparative genomic hybridizationJoel Greshock, Katherine Nathanson, Anne-Marie Martin, et al.
Medical Physics|April 9, 2004
Computerized analysis of mammographic parenchymal patterns for assessing breast cancer risk: effect of ROI size and locationHui Li, Maryellen L Giger, Zhimin Huo, et al.
Cancer Research|August 18, 2004
SPRY2 is an inhibitor of the ras/extracellular signal-regulated kinase pathway in melanocytes and melanoma cells with wild-type BRAF but not with the V599E mutantDimitra Tsavachidou, Mathew L Coleman, Galene Athanasiadis, et al.
Journal of the National Cancer Institute|September 19, 2002
Cancer risk estimates for BRCA1 mutation carriers identified in a risk evaluation programMarcia S Brose, Timothy R Rebbeck, Kathleen A Calzone, et al.
Human Molecular Genetics|May 23, 2002
CGH-targeted linkage analysis reveals a possible BRCA1 modifier locus on chromosome 5qKatherine L Nathanson, Yin Y Shugart, Romaica Omaruddin, et al.
Pageof 9

Showing results (11-20 of 82) with videos related to

Sort By:
Pageof 9
Cancer Letters|June 22, 2005
Measurement and relevance of neuroblastoma DNA copy number changes in the post-genome eraYael P Mosse, Joel Greshock, Barbara L Weber, et al.
Journal of Consulting and Clinical Psychology|February 28, 2002
Why not to screen high-risk women anticipating BRCA1/BRCA2 testing for psychological distressNili R Benazon, James C Coyne, Kathleen A Calzone, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 15, 2003
Application of breast cancer risk prediction models in clinical practiceSusan M Domchek, Andrea Eisen, Kathleen Calzone, et al.
The Lancet. Oncology|December 10, 2003
Identification and high-resolution mapping of a constitutional 11q deletion in an infant with multifocal neuroblastomaYael Mosse, Joel Greshock, Allison King, et al.
Cancer Research|June 3, 2004
Structure-based assessment of missense mutations in human BRCA1: implications for breast and ovarian cancer predispositionNebojsa Mirkovic, Marc A Marti-Renom, Barbara L Weber, et al.
Cancer Research|April 19, 2007
Cancer cell lines as genetic models of their parent histology: analyses based on array comparative genomic hybridizationJoel Greshock, Katherine Nathanson, Anne-Marie Martin, et al.
Medical Physics|April 9, 2004
Computerized analysis of mammographic parenchymal patterns for assessing breast cancer risk: effect of ROI size and locationHui Li, Maryellen L Giger, Zhimin Huo, et al.
Cancer Research|August 18, 2004
SPRY2 is an inhibitor of the ras/extracellular signal-regulated kinase pathway in melanocytes and melanoma cells with wild-type BRAF but not with the V599E mutantDimitra Tsavachidou, Mathew L Coleman, Galene Athanasiadis, et al.
Journal of the National Cancer Institute|September 19, 2002
Cancer risk estimates for BRCA1 mutation carriers identified in a risk evaluation programMarcia S Brose, Timothy R Rebbeck, Kathleen A Calzone, et al.
Human Molecular Genetics|May 23, 2002
CGH-targeted linkage analysis reveals a possible BRCA1 modifier locus on chromosome 5qKatherine L Nathanson, Yin Y Shugart, Romaica Omaruddin, et al.
Pageof 9